SVNS · LONDON STOCK EXCHANGE ·
Solvonis Therapeutics plc
US Patent Office allows ketamine patent
Our AI’s take
Solvonis reports that the USPTO has allowed its US method-of-use patent application covering behavioural addictions treated with ketamine at dissociative doses…
The full digestion is for members. What is good, what is bad and why, the numbers that matter, and the chart, then ask about it by voice or text.
Join freeNew to announcements? Learn what an RNS is and why prices move.